skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Adult remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia

Stein, Eytan M. ; Garcia-Manero, Guillermo ; Rizzieri, David A. ; Tibes, Raoul ; Berdeja, Jesus G. ; Savona, Michael R. ; Jongen-Lavrenic, Mojca ; Altman, Jessica K. ; Thomson, Blythe ; Blakemore, Stephen J. ; Daigle, Scott R. ; Waters, Nigel J. ; Suttle, A. Benjamin ; Clawson, Alicia ; Pollock, Roy ; Krivtsov, Andrei ; Armstrong, Scott A. ; DiMartino, Jorge ; Hedrick, Eric ; Löwenberg, Bob ; Tallman, Martin S.

Blood, 2018-06, Vol.131 (24), p.2661-2669 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm

Pemmaraju, Naveen ; Lane, Andrew A ; Sweet, Kendra L ; Stein, Anthony S ; Vasu, Sumithira ; Blum, William ; Rizzieri, David A ; Wang, Eunice S ; Duvic, Madeleine ; Sloan, J. Mark ; Spence, Sharon ; Shemesh, Shay ; Brooks, Christopher L ; Balser, John ; Bergstein, Ivan ; Lancet, Jeffrey E ; Kantarjian, Hagop M ; Konopleva, Marina

The New England journal of medicine, 2019-04, Vol.380 (17), p.1628-1637 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
3
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

KHOURY, H. J ; KUKREJA, M ; GALE, R. P ; MARKS, D. I ; MCCARTHY, P. L ; WOOLFREY, A ; SZER, J ; GIRALT, S. A ; MAZIARZ, R. T ; CORTES, J ; HOROWITZ, M. M ; LEE, S. J ; GOLDMAN, J. M ; WANG, T ; HALTER, J ; ARORA, M ; GUPTA, V ; RIZZIERI, D. A ; GEORGE, B ; KEATING, A

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.810-816 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors
Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors

Laughlin, Mary J ; Barker, Juliet ; Bambach, Barbara ; Koc, Omer N ; Rizzieri, David A ; Wagner, John E ; Gerson, Stanton L ; Lazarus, Hillard M ; Cairo, Mitchell ; Stevens, Cladd E ; Rubinstein, Pablo ; Kurtzberg, Joanne

The New England journal of medicine, 2001-06, Vol.344 (24), p.1815-1822 [Periódico revisado por pares]

Boston, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
5
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment

KANDA, J ; KAYNAR, L ; GASPARETTO, C ; CHUTE, J. P ; MORRIS, A ; WINKEL, S ; MCPHERSON, J ; KURTZBERG, J ; CHAO, N. J ; HORWITZ, M. E ; KANDA, Y ; PRASAD, V. K ; PARIKH, S. H ; LAN, L ; SHEN, T ; RIZZIERI, D. A ; LONG, G. D ; SULLIVAN, K. M

Bone marrow transplantation (Basingstoke), 2013-07, Vol.48 (7), p.926-931 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies
A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies

Rizzieri, David A ; Feldman, Eric ; Dipersio, John F ; Gabrail, Nashat ; Stock, Wendy ; Strair, Roger ; Rivera, Victor M ; Albitar, Maher ; Bedrosian, Camille L ; Giles, Francis J

Clinical cancer research, 2008-05, Vol.14 (9), p.2756-2762 [Periódico revisado por pares]

United States: American Association for Cancer Research

Texto completo disponível

Citações Citado por
7
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study

Issa, Jean-Pierre J, Prof ; Roboz, Gail, Prof ; Rizzieri, David, Prof ; Jabbour, Elias, MD ; Stock, Wendy, Prof ; O'Connell, Casey, MD ; Yee, Karen, MD ; Tibes, Raoul, MD ; Griffiths, Elizabeth A, MD ; Walsh, Katherine, MD ; Daver, Naval, MD ; Chung, Woonbok, PhD ; Naim, Sue, BS ; Taverna, Pietro, PhD ; Oganesian, Aram, PhD ; Hao, Yong, MD ; Lowder, James N, MD ; Azab, Mohammad, MD ; Kantarjian, Hagop, Prof

The lancet oncology, 2015-09, Vol.16 (9), p.1099-1110 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration

HORWITZ, M. E ; CHUTE, J. P ; GASPARETTO, C ; LONG, G. D ; MCDONALD, C ; MORRIS, A ; RIZZIERI, D. A ; SULLIVAN, K. M ; CHAO, N. J

Bone marrow transplantation (Basingstoke), 2012-08, Vol.47 (8), p.1051-1055 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment
Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment

Horwitz, Mitchell E ; Chao, Nelson J ; Rizzieri, David A ; Long, Gwynn D ; Sullivan, Keith M ; Gasparetto, Cristina ; Chute, John P ; Morris, Ashley ; McDonald, Carolyn ; Waters-Pick, Barbara ; Stiff, Patrick ; Wease, Steven ; Peled, Amnon ; Snyder, David ; Cohen, Einat Galamidi ; Shoham, Hadas ; Landau, Efrat ; Friend, Etty ; Peleg, Iddo ; Aschengrau, Dorit ; Yackoubov, Dima ; Kurtzberg, Joanne ; Peled, Tony

The Journal of clinical investigation, 2014-07, Vol.124 (7), p.3121-3128 [Periódico revisado por pares]

United States: American Society for Clinical Investigation

Texto completo disponível

Citações Citado por
10
Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk Factors
Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk Factors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk Factors

Kelsey, Chris R., M.D ; Horwitz, Mitchell E., M.D ; Chino, Junzo P., M.D ; Craciunescu, Oana, Ph.D ; Steffey, Beverly, M.S ; Folz, Rodney J., M.D. Ph.D ; Chao, Nelson J., M.D ; Rizzieri, David A., M.D ; Marks, Lawrence B., M.D

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (3), p.812-818 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (60)

Data de Publicação 

De até
Refinar
  1. Antes de2002  (6)
  2. 2002Até2007  (13)
  3. 2008Até2011  (18)
  4. 2012Até2016  (27)
  5. Após 2016  (20)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.